CRISPR

The Top Line
Podcast

Biopharma briefing: Q1 trends, gene therapy news, ASCO preview

In this episode of "The Top Line," we break down first-quarter Big Pharma earnings, recap gene therapy developments and preview what’s ahead at ASCO.
photo of a green light on a stoplight

NICE signs off on Vertex, CRISPR's Casgevy for beta thalassemia

Aug 7, 2024 8:20pm
Biovectra manufacturing

Agilent will pay $925M to acquire specialty CDMO Biovectra

Jul 22, 2024 11:01am
partnership collaboration legal document

Michigan Medicaid signs deal with bluebird for SCD gene therapy

Mar 11, 2024 11:00am
The Top Line

'The Top Line': Gene editing's next act

Feb 16, 2024 8:55am
Vertex

Vertex's sales of Trikafta hit $8.9B thanks to label expansion

Feb 6, 2024 12:39pm